• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Basic Materials·1379.T
Share

Hokuto Corporation Stocks

¥ 2083Last Updated 15.10.2026

Issuer Rating

6/7
Performance

Strong

Risk

Limited

Recommendation

Buy

Market Cap

¥ 398.79M

¥ 2083
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in Nagano, Japan, Hokuto Corporation primarily focuses on the research, cultivation, and distribution of mushrooms across its home country. Their extensive product line features varieties such as Eryngii, Maitake, Bunashimeji, Bunapi, and Shimofuri Hiratake. Beyond fungal production, the company diversifies its activities by manufacturing and marketing plastic goods, providing materials and machinery for agricultural purposes, and engaging in the cultivation, processing, and sale of various other agricultural products. Internationally, Hokuto maintains operations in the United States, Taiwan, and Malaysia. Founded in 1964, the organization adopted its present name, Hokuto Corporation, in October 2003, having previously operated as Hokuto Industry Corporation.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.10.2026 15:00

Iambic IPO: Trading Begins in the Biotech Stock, Backed by Nvidia and Cathie Wood

15.10.2026 14:25

Nvidia, AMD, and Micron fell in U.S. pre-market trading. The sell-off in AI stocks continues

15.10.2026 13:52

Smartphone shipments plummeted 22% last quarter—the worst decline on record

15.10.2026 12:53

Anthropic's revenue surge will help its IPO, but is unlikely to save the entire AI sector, experts say

15.10.2026 12:37

"They Started Catching Up Late, but Quickly": Movchan's Group Guide to Investing in Kazakhstan

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026